Get the Stockscreener App
14.70
2.00%
-0.30
After Hours:
15.10
0.40
+2.72%
Minimed Group Inc stock is traded at $14.70, with a volume of 438.96K.
It is down -2.00% in the last 24 hours and up +36.11% over the past month.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
See More
Previous Close:
$15.00
Open:
$15.04
24h Volume:
438.96K
Relative Volume:
0.50
Market Cap:
$4.13B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-12.87
EPS:
-1.142
Net Cash Flow:
-
1W Performance:
-2.78%
1M Performance:
+36.11%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$14.70
$15.36
1-Week Range:
$14.24
$15.68
52-Week Range:
$10.65
$19.05
Minimed Group Inc Stock (MMED) Company Profile
Name
Minimed Group Inc
Sector
Industry
Phone
763-222-9423
Address
18000 DEVONSHIRE ST., NORTHRIDGE
Compare MMED vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MMED
Minimed Group Inc
|
14.70 | 4.21B | 0 | 0 | 0 | -1.142 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Minimed Group Inc Stock (MMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-26 | Initiated | BTIG Research | Buy |
| Mar-31-26 | Initiated | BofA Securities | Buy |
| Mar-31-26 | Initiated | Citigroup | Buy |
| Mar-31-26 | Initiated | Deutsche Bank | Buy |
| Mar-31-26 | Initiated | Evercore ISI | Outperform |
| Mar-31-26 | Initiated | Goldman | Buy |
| Mar-31-26 | Initiated | Mizuho | Outperform |
| Mar-31-26 | Initiated | Morgan Stanley | Overweight |
| Mar-31-26 | Initiated | Piper Sandler | Neutral |
| Mar-31-26 | Initiated | Wells Fargo | Overweight |
| Mar-31-26 | Initiated | William Blair | Outperform |
View All
Minimed Group Inc Stock (MMED) Latest News
MMED Q1 2026 Earnings: EPS Falls Far Short of EstimatesLow Growth Earnings - newsline.com
Is Medtronic's MiniMed Spin-Off a Smart Bet for Investors - Kavout
Benchmark reiterates MiniMed Group stock rating on product launches By Investing.com - Investing.com Canada
MMED Price Today: MiniMed Group, Inc. Stock Price, Quote & Chart | MEXC - MEXC
MMED's latest study supports the strength of 780G SmartGuard algorithm - MSN
Wells Fargo Maintains MiniMed Group(MMED.US) With Buy Rating, Raises Target Price to $26 - Moomoo
MiniMed Group Inc. (MMED) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
A Look At MiniMed Group (MMED) Valuation After Recent Share Price Volatility - Yahoo Finance
BofA Securities Maintains MiniMed Group(MMED.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Evercore Maintains MiniMed Group(MMED.US) With Buy Rating, Maintains Target Price $20 - Moomoo
A Quick Look at Today's Ratings for MiniMed Group(MMED.US), With a Forecast Between $16 to $25 - Moomoo
Piper Sandler reiterates Neutral rating on MiniMed stock at $16 - Investing.com
Piper Sandler reiterates Neutral rating on MiniMed stock at $16 By Investing.com - Investing.com India
MiniMed Fiscal Q4 Loss Unchanged, Revenue Rises; Shares Up Pre-Bell - Moomoo
MiniMed Closes FY26 On A Strong Note, Eyes Long-Term Growth - RTTNews
MiniMed (MMED) Reports Strong Q4 Revenue Growth - GuruFocus
Minimed Group Inc (MMED) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Product ... By GuruFocus - Investing.com Canada
MMED Projects 16% Adjusted EBITDA Margin by FY27 - GuruFocus
Why Medtronic Stock Popped Today - Yahoo Finance
MiniMed Group Inc. (MMED) Surges 12.93% as Bulls Test Key Resistance LevelStock Buy Zone - newsline.com
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday - Benzinga
MiniMed Stock Surges 11% to $13.69 After Strong Q4 Results and Bullish 2027 Outlook - International Business Times Australia
MMED: Record revenue, robust pipeline, and 10% organic growth outlook for FY 2027 - TradingView
Earnings call transcript: MiniMed sees strong Q4 2026 growth, stock rises By Investing.com - Investing.com South Africa
MiniMed Group Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: MiniMed sees strong Q4 2026 growth, stock rises - Investing.com
MMED: Record revenue, robust pipeline, and 10% growth outlook highlight strong momentum - TradingView
MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion - marketscreener.com
Full Transcript: Minimed Group Q4 2026 Earnings Call - Benzinga
MiniMed Group Q4 2026 Earnings Call Transcript - MarketBeat
MiniMed Group, Inc. Reports Earnings Results for the Fourth Quarter Ended April 24, 2026 - marketscreener.com
Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years - Medtronic
MMED: FY26 revenue surpassed $3B with strong growth and FY27 guidance targets further margin expansion - TradingView
Minimed: Fiscal Q4 Earnings Snapshot - marketscreener.com
Earnings Flash (MMED) MiniMed Reports Q4 Revenue $837.0M, vs. FactSet Est of $827.9M - marketscreener.com
MiniMed partners with Abbott on dual glucose-ketone sensors By Investing.com - Investing.com Canada
MMED: Record $3B+ sales, strong international growth, and FY27 guidance for 10% organic revenue growth - TradingView
MiniMed (MMED) grows revenue to $3.1B in FY 2026 but widens loss - Stock Titan
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott - marketscreener.com
MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook - marketscreener.com
New diabetes sensor tracks ketones to spot DKA risk earlier - Stock Titan
Diabetes tech firm MiniMed tops $3.1B sales, sees 10% organic growth in FY27 - Stock Titan
MiniMed prices IPO at $20 per share, to trade on Nasdaq - Investing.com India
MiniMed: Waiting For The First Earnings Report (NASDAQ:MMED) - Seeking Alpha
MiniMed Group Inc. (MMED) Edges Higher in Quiet TradingRisk Reward Setups - newsline.com
Citi Maintains MiniMed Group(MMED.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Medtronic: Almost A Buy Now (NYSE:MDT) - Seeking Alpha
Operating margin % of MiniMed Group, Inc. – LS:A420FV - TradingView
Minimed Group Inc Stock (MMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.68%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):